Screening and Brief Advice to Reduce Teen Substance Use
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).
We hypothesize that:
- Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use;
- Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use;
- Among 12-18 year old well care patients who are at risk for driving/riding while impaired (DRWI), the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing DRWI risk behavior as measured by a standardized scale.
| Condition | Intervention | Phase |
|---|---|---|
|
Substance Related Disorders |
Behavioral: Computerized CRAFFT screen and brief physician advice |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Screening and Brief Advice to Reduce Teen Substance Use |
- Percent days abstinent from substance use [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
- Cessation of substance use [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
- Initiation of substance use [ Time Frame: Past 90 days ] [ Designated as safety issue: No ]
- DWI/RWID [ Time Frame: past 90 days ] [ Designated as safety issue: Yes ]DWI - driving under the influence of substances RWID - riding with a driver who has been using substances
| Enrollment: | 2145 |
| Study Start Date: | September 2004 |
| Study Completion Date: | February 2010 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Control
Control participants will receive "care as usual" from their provider
|
Behavioral: Computerized CRAFFT screen and brief physician advice
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Other Name: SBIRT
|
|
Experimental: Screening and Brief Advice
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
|
Behavioral: Computerized CRAFFT screen and brief physician advice
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Other Name: SBIRT
|
Detailed Description:
We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.
We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic.
Eligibility| Ages Eligible for Study: | 12 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
12-18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English
Exclusion Criteria:
Will not be available for 12 month follow-up period, Medically unstable at the time of the visit
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00227877
| United States, Massachusetts | |
| Tufts-New England Medical Center | |
| Boston, Massachusetts, United States, 02111 | |
| Cambridge Pediatrics | |
| Cambridge, Massachusetts, United States, 02139 | |
| Fallon Clinic | |
| Worcester, Massachusetts, United States, 01605 | |
| United States, New Hampshire | |
| Capital Region Family Health Center | |
| Concord, New Hampshire, United States, 03301 | |
| United States, Vermont | |
| Milton Family Practice | |
| Milton, Vermont, United States, 05468 | |
| Czech Republic | |
| Center for the Evaluation, Prevention, and Research of Substance Abuse | |
| Prague, Czech Republic | |
| Principal Investigator: | John R Knight, M.D. | Children's Hospital Boston |
More Information
Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | John R. Knight, MD, Children's Hospital Boston |
| ClinicalTrials.gov Identifier: | NCT00227877 History of Changes |
| Obsolete Identifiers: | NCT00592878, NCT00592956 |
| Other Study ID Numbers: | NIDA-R01DA0118848 |
| Study First Received: | September 27, 2005 |
| Last Updated: | June 16, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Hospital Boston:
|
alcohol abuse substance abuse substance related disorders |
Additional relevant MeSH terms:
|
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |
ClinicalTrials.gov processed this record on March 03, 2015